OSR HEALTH INC (OSRH)
Institutional ownership reported to the SEC as of Q2 2026, across 6 quarters.
Institutions report 656,511 shares against 35,118,692 outstanding. Shares only - option lines are excluded, which is why this can be compared with the company at all. The count comes from the cover page of the company's own most recent report, so it is dated when that was filed rather than at quarter end.
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| VANGUARD FIDUCIARY TRUST CO | $46.9K | 148,266 | 0.00% | 2q | +770.7%+$41.5K |
| CITADEL ADVISORS LLC | $40.4K | 127,810 | 0.00% | new | NEW |
| JANE STREET GROUP, LLC | $40.2K | 127,195 | 0.00% | new | NEW |
| GEODE CAPITAL MANAGEMENT, LLC | $31.8K | 100,458 | 0.00% | 4q | -5.0%-$1.7K |
| TWO SIGMA SECURITIES, LLC | $14.7K | 46,537 | 0.00% | new | NEW |
| VANGUARD CAPITAL MANAGEMENT LLC | $11.8K | 37,373 | 0.00% | 2q | HELD |
| XTX Topco Ltd | $10.2K | 32,380 | 0.00% | 2q | -46.7%-$9.0K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.8K | 18,282 | 0.00% | new | NEW |
| NORTHERN TRUST CORP | $3.5K | 10,906 | 0.00% | new | NEW |
| Tower Research Capital LLC (TRC) | $2.1K | 6,587 | 0.00% | 6q | +59.1% |
| UBS Group AG | $183 | 580 | 0.00% | 3q | -87.0%-$1.2K |
| SBI Securities Co., Ltd. | $43 | 137 | 0.00% | 6q | +77.9% |
| Mint Tower Capital Management B.V. | $2 | 7,500 | 0.00% | 6q | HELD |
Five percent filings
Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →
| Filed | Form | Filer | % of class |
|---|---|---|---|
| 2026-08-17 | 13G/A | joint protein central inc. | 3.4% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 12 | $207.6K | 656,511 | 5 | 3 | 3 | 0.0% |
| Q1 2026 | 10 | $172.1K | 285,404 | 3 | 3 | 1 | 0.0% |
| Q4 2025 | 10 | $93.3K | 165,540 | 5 | 1 | 1 | 0.0% |
| Q3 2025 | 7 | $116.4K | 217,625 | 4 | 2 | 0 | 0.0% |
| Q2 2025 | 6 | $83.7K | 60,912 | 1 | 3 | 1 | 0.0% |
| Q1 2025 | 7 | $104.2K | 55,411 | 7 | 0 | 0 | 0.0% |